MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA-c) is a mitochondrial-derived peptide (MDP) that has emerged as one of the most compelling discoveries in metabolic and longevity research. First identified in 2015 by Dr Pinchas Cohen's laboratory at the University of Southern California, MOTS-c is encoded not by nuclear DNA — the genome we typically think of — but by the mitochondrial genome itself. This discovery fundamentally challenged the prevailing view that mitochondrial DNA (mtDNA) primarily encodes proteins for oxidative phosphorylation. Instead, MOTS-c revealed that mitochondria function as signalling organelles, producing peptides that communicate with the nucleus and regulate whole-body metabolism.
Unlike conventional peptide hormones that are produced in endocrine glands and travel through the bloodstream, MOTS-c is produced inside mitochondria and acts primarily in an autocrine and paracrine manner — meaning it influences the cells that produce it and their immediate neighbours. This unique origin and mode of action places MOTS-c at the intersection of mitochondrial biology, metabolic regulation, and the emerging field of mitokine signalling. In this article, we examine the current research on MOTS-c, its mechanisms of action, and its potential implications for metabolic health and longevity studies.
Discovery and Origin of MOTS-c
The discovery of MOTS-c was part of a broader paradigm shift in our understanding of the mitochondrial genome. For decades, the 37 genes encoded by mtDNA were thought to be exclusively involved in oxidative phosphorylation — the process by which cells convert nutrients into ATP, the body's energy currency. However, in 2015, Cohen and colleagues published a landmark paper in the journal Cell Metabolism demonstrating that a region of the mitochondrial 12S ribosomal RNA gene — previously considered non-coding — actually encodes a functional 16-amino-acid peptide. They named this peptide MOTS-c, reflecting its origin in the mitochondrial open reading frame of the 12S rRNA.
The discovery was particularly significant because it showed that mitochondria, long viewed as the cell's passive power plants, are active participants in cellular signalling. By producing peptides like MOTS-c, mitochondria can directly influence nuclear gene expression, metabolic pathways, and even the body's response to environmental stressors such as exercise and caloric restriction. A detailed review of this discovery and its implications is available through PubMed, where a growing body of literature documents the expanding family of mitochondrial-derived peptides.
Mechanism of Action: How MOTS-c Regulates Metabolism
MOTS-c exerts its metabolic effects primarily through the activation of AMP-activated protein kinase (AMPK) — a master regulator of cellular energy homeostasis. AMPK is often described as the body's fuel gauge: it is activated when cellular energy levels are low (high AMP/ATP ratio) and acts to restore energy balance by stimulating catabolic pathways (glucose uptake, fatty acid oxidation) while inhibiting anabolic processes (fat storage, protein synthesis). MOTS-c appears to activate AMPK through a mechanism involving the folate cycle and purine nucleotide biosynthesis, linking mitochondrial signalling to the cell's central energy-sensing network.
Studies have shown that MOTS-c treatment increases the expression of genes involved in glucose metabolism, including GLUT4 (the insulin-responsive glucose transporter) and enzymes of glycolysis. It also enhances fatty acid oxidation by upregulating carnitine palmitoyltransferase 1 (CPT1), the rate-limiting enzyme for mitochondrial fatty acid import. These effects together improve the cell's capacity to utilise both glucose and lipids for energy production — a metabolic flexibility that is often impaired in insulin resistance and type 2 diabetes. Research indexed on the National Library of Medicine provides comprehensive data on these mechanisms.
Beyond AMPK activation, MOTS-c has been shown to interact with the folate and methionine cycles — one-carbon metabolism pathways that are central to nucleotide synthesis, methylation reactions, and redox balance. By modulating these pathways, MOTS-c influences the availability of methyl donors and affects the epigenetic landscape of the cell. This connection between mitochondrial signalling and epigenetic regulation opens intriguing possibilities for understanding how environmental factors like diet and exercise influence gene expression through mitochondrial intermediaries.
Metabolic Health Research: Glucose Metabolism and Insulin Sensitivity
Perhaps the most extensively studied aspect of MOTS-c biology is its role in glucose metabolism and insulin sensitivity. In preclinical models, administration of MOTS-c has been shown to improve glucose tolerance and enhance insulin sensitivity in both diet-induced obese and aged mice. These effects are mediated in part through increased glucose uptake in skeletal muscle — the body's primary tissue for glucose disposal after a meal. Muscle cells treated with MOTS-c show enhanced translocation of GLUT4 to the cell surface, a process that is typically impaired in insulin-resistant states.
A particularly striking finding is that MOTS-c appears to mimic some of the beneficial metabolic effects of exercise. When administered to sedentary mice, MOTS-c improves glucose disposal and enhances fatty acid oxidation in a manner similar to that observed in exercised animals. This has led researchers to describe MOTS-c as an "exercise mimetic" — a compound that activates some of the same metabolic pathways as physical activity. While it is important to distinguish between molecular mimicry and the full physiological benefits of exercise, this property makes MOTS-c a subject of intense research interest for metabolic health applications. Clinical studies catalogued on ClinicalTrials.gov continue to explore the therapeutic potential of this pathway.
Age-Related Metabolic Decline and Longevity Research
One of the most intriguing dimensions of MOTS-c research concerns its relationship with ageing. Circulating levels of MOTS-c decline with age in both rodents and humans — a finding that parallels the age-related decline seen in other mitochondrial-derived peptides and in NAD+ levels. This decline is thought to contribute to the metabolic dysfunction that characterises ageing, including increased insulin resistance, reduced mitochondrial function, and decreased exercise capacity.
In preclinical studies, restoring MOTS-c levels in aged animals has been associated with improvements in metabolic function, increased physical activity, and extended healthspan — the period of life spent in good health. While healthspan extension does not necessarily equate to lifespan extension, the distinction is important: MOTS-c research focuses on improving the quality of metabolic health during ageing rather than simply extending chronological lifespan. The peptide's effects on AMPK activation, mitochondrial function, and one-carbon metabolism overlap with pathways targeted by other longevity interventions, including NAD+ precursors and caloric restriction mimetics. For researchers exploring these intersections, MOTS-c offers a complementary mechanism to compounds like NAD+ in cellular energy and ageing studies. Our article on NAD+ and cellular health provides further context on how these pathways interact.
MOTS-c in the Context of BioMuti's Research Peptide Range
For researchers investigating metabolic pathways, MOTS-c is a valuable addition to the peptide research arsenal. Its mechanism of action — centred on AMPK activation, glucose metabolism, and fatty acid oxidation — is distinct from that of other compounds in the BioMuti range. While BPC-157 targets tissue repair through angiogenesis and growth factor modulation, and TB-500 promotes cell migration and wound healing, MOTS-c offers a window into mitochondrial signalling and metabolic regulation. This diversity of mechanisms allows researchers to design comprehensive experimental protocols that address different aspects of cellular function and health.
The combination of MOTS-c with NAD+ precursors is a particularly active area of investigation, as both compounds target cellular energy metabolism through complementary pathways — NAD+ as a coenzyme for redox reactions and sirtuin activation, and MOTS-c as a signalling peptide that activates AMPK and modulates one-carbon metabolism. For a broader overview of how researchers combine different peptides synergistically, see our guide to peptide stacking.
Safety and Research-Grade Quality
As a naturally occurring mitochondrial peptide, MOTS-c has shown a favourable safety profile in preclinical studies. Its mechanism of action — activating pathways that the body already uses to regulate metabolism — suggests a low risk of off-target effects when used appropriately in controlled research settings. As with all research peptides, MOTS-c is intended for laboratory investigation only and has not been evaluated by SAHPRA for human use.
BioMuti's MOTS-c is synthesised to 99%+ purity and independently tested by accredited South African laboratories. Each batch is verified for peptide content, molecular weight, and purity, ensuring that researchers can rely on consistent quality across experimental runs. For laboratories and institutions requiring bulk materials for multi-experiment programmes, our wholesale program offers tiered pricing and batch reservation services.
BioMuti's Commitment to Metabolic Research
At BioMuti, we believe that understanding the signalling molecules produced by our own cells — including mitochondrial-derived peptides like MOTS-c — is essential to advancing metabolic science. The discovery of MOTS-c fundamentally changed our understanding of mitochondria, revealing them as active participants in the dialogue between cellular energy status, gene expression, and whole-body metabolism. We are proud to support researchers investigating this frontier with the highest quality research compounds.
Whether your research focuses on insulin sensitivity, mitochondrial function, metabolic flexibility, or the intersection of peptide signalling with age-related metabolic decline, our product range offers the quality and consistency your laboratory demands. Browse our full range of research-grade peptides, including MOTS-c, NAD+, BPC-157, TB-500, GHK-Cu, and more. For further reading, explore our articles on NAD+ and cellular energy, our complete guide to BioMuti peptides, and our overview of South African peptide regulations.
MOTS-c represents a remarkable chapter in the story of mitochondrial biology — a reminder that even the most well-studied cellular compartments still hold surprises. At BioMuti, we are committed to supplying the research community with the tools needed to uncover those secrets.
